Last updated on April 2018

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution


Brief description of study

Open label study to assess safety, tolerability, and efficacy of ATI-50002 in male and female subjects with androgenetic alopecia.

Detailed Study Description

This is an open-label study designed to evaluate the safety and efficacy of ATI-50002 Topical Solution in male and female subjects with androgenetic alopecia.

Clinical Study Identifier: NCT03495817

Contact Investigators or Research Sites near you

Start Over

Judy Schnyder

Aclaris Investigational Site
Denver, CO United States
  Connect »

Judy Schnyder

Aclaris Investigational Site
Portland, OR United States
  Connect »

Judy Schnyder

Aclaris Investigational Site
Austin, TX United States
  Connect »